Neprilysin-Global Market Status and Trend Report 2013-2023
Report Summary
Neprilysin-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Neprilysin industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Neprilysin 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Neprilysin worldwide, with company and product introduction, position in the Neprilysin market
Market status and development trend of Neprilysin by types and applications
Cost and profit status of Neprilysin, and marketing status
Market growth drivers and challenges
The report segments the global Neprilysin market as:
Global Neprilysin Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Neprilysin Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
TD-0714
STR-324
PL-265
LHW-090
Others
Global Neprilysin Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Acute Heart Failure
Cancer Pain
Hypertension
Alzheimer's Disease
Others
Global Neprilysin Market: Manufacturers Segment Analysis (Company and Product introduction, Neprilysin Sales Volume, Revenue, Price and Gross Margin):
Bioprojet SCR
Novartis AG
Pharmaleads SA
Theravance Biopharma Inc
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Neprilysin-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Neprilysin industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Neprilysin 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Neprilysin worldwide, with company and product introduction, position in the Neprilysin market
Market status and development trend of Neprilysin by types and applications
Cost and profit status of Neprilysin, and marketing status
Market growth drivers and challenges
The report segments the global Neprilysin market as:
Global Neprilysin Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Neprilysin Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
TD-0714
STR-324
PL-265
LHW-090
Others
Global Neprilysin Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Acute Heart Failure
Cancer Pain
Hypertension
Alzheimer's Disease
Others
Global Neprilysin Market: Manufacturers Segment Analysis (Company and Product introduction, Neprilysin Sales Volume, Revenue, Price and Gross Margin):
Bioprojet SCR
Novartis AG
Pharmaleads SA
Theravance Biopharma Inc
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF NEPRILYSIN
1.1 Definition of Neprilysin in This Report
1.2 Commercial Types of Neprilysin
1.2.1 TD-0714
1.2.2 STR-324
1.2.3 PL-265
1.2.4 LHW-090
1.2.5 Others
1.3 Downstream Application of Neprilysin
1.3.1 Acute Heart Failure
1.3.2 Cancer Pain
1.3.3 Hypertension
1.3.4 Alzheimer's Disease
1.3.5 Others
1.4 Development History of Neprilysin
1.5 Market Status and Trend of Neprilysin 2013-2023
1.5.1 Global Neprilysin Market Status and Trend 2013-2023
1.5.2 Regional Neprilysin Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Neprilysin 2013-2017
2.2 Sales Market of Neprilysin by Regions
2.2.1 Sales Volume of Neprilysin by Regions
2.2.2 Sales Value of Neprilysin by Regions
2.3 Production Market of Neprilysin by Regions
2.4 Global Market Forecast of Neprilysin 2018-2023
2.4.1 Global Market Forecast of Neprilysin 2018-2023
2.4.2 Market Forecast of Neprilysin by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Neprilysin by Types
3.2 Sales Value of Neprilysin by Types
3.3 Market Forecast of Neprilysin by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Neprilysin by Downstream Industry
4.2 Global Market Forecast of Neprilysin by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Neprilysin Market Status by Countries
5.1.1 North America Neprilysin Sales by Countries (2013-2017)
5.1.2 North America Neprilysin Revenue by Countries (2013-2017)
5.1.3 United States Neprilysin Market Status (2013-2017)
5.1.4 Canada Neprilysin Market Status (2013-2017)
5.1.5 Mexico Neprilysin Market Status (2013-2017)
5.2 North America Neprilysin Market Status by Manufacturers
5.3 North America Neprilysin Market Status by Type (2013-2017)
5.3.1 North America Neprilysin Sales by Type (2013-2017)
5.3.2 North America Neprilysin Revenue by Type (2013-2017)
5.4 North America Neprilysin Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Neprilysin Market Status by Countries
6.1.1 Europe Neprilysin Sales by Countries (2013-2017)
6.1.2 Europe Neprilysin Revenue by Countries (2013-2017)
6.1.3 Germany Neprilysin Market Status (2013-2017)
6.1.4 UK Neprilysin Market Status (2013-2017)
6.1.5 France Neprilysin Market Status (2013-2017)
6.1.6 Italy Neprilysin Market Status (2013-2017)
6.1.7 Russia Neprilysin Market Status (2013-2017)
6.1.8 Spain Neprilysin Market Status (2013-2017)
6.1.9 Benelux Neprilysin Market Status (2013-2017)
6.2 Europe Neprilysin Market Status by Manufacturers
6.3 Europe Neprilysin Market Status by Type (2013-2017)
6.3.1 Europe Neprilysin Sales by Type (2013-2017)
6.3.2 Europe Neprilysin Revenue by Type (2013-2017)
6.4 Europe Neprilysin Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Neprilysin Market Status by Countries
7.1.1 Asia Pacific Neprilysin Sales by Countries (2013-2017)
7.1.2 Asia Pacific Neprilysin Revenue by Countries (2013-2017)
7.1.3 China Neprilysin Market Status (2013-2017)
7.1.4 Japan Neprilysin Market Status (2013-2017)
7.1.5 India Neprilysin Market Status (2013-2017)
7.1.6 Southeast Asia Neprilysin Market Status (2013-2017)
7.1.7 Australia Neprilysin Market Status (2013-2017)
7.2 Asia Pacific Neprilysin Market Status by Manufacturers
7.3 Asia Pacific Neprilysin Market Status by Type (2013-2017)
7.3.1 Asia Pacific Neprilysin Sales by Type (2013-2017)
7.3.2 Asia Pacific Neprilysin Revenue by Type (2013-2017)
7.4 Asia Pacific Neprilysin Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Neprilysin Market Status by Countries
8.1.1 Latin America Neprilysin Sales by Countries (2013-2017)
8.1.2 Latin America Neprilysin Revenue by Countries (2013-2017)
8.1.3 Brazil Neprilysin Market Status (2013-2017)
8.1.4 Argentina Neprilysin Market Status (2013-2017)
8.1.5 Colombia Neprilysin Market Status (2013-2017)
8.2 Latin America Neprilysin Market Status by Manufacturers
8.3 Latin America Neprilysin Market Status by Type (2013-2017)
8.3.1 Latin America Neprilysin Sales by Type (2013-2017)
8.3.2 Latin America Neprilysin Revenue by Type (2013-2017)
8.4 Latin America Neprilysin Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Neprilysin Market Status by Countries
9.1.1 Middle East and Africa Neprilysin Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Neprilysin Revenue by Countries (2013-2017)
9.1.3 Middle East Neprilysin Market Status (2013-2017)
9.1.4 Africa Neprilysin Market Status (2013-2017)
9.2 Middle East and Africa Neprilysin Market Status by Manufacturers
9.3 Middle East and Africa Neprilysin Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Neprilysin Sales by Type (2013-2017)
9.3.2 Middle East and Africa Neprilysin Revenue by Type (2013-2017)
9.4 Middle East and Africa Neprilysin Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF NEPRILYSIN
10.1 Global Economy Situation and Trend Overview
10.2 Neprilysin Downstream Industry Situation and Trend Overview
CHAPTER 11 NEPRILYSIN MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Neprilysin by Major Manufacturers
11.2 Production Value of Neprilysin by Major Manufacturers
11.3 Basic Information of Neprilysin by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Neprilysin Major Manufacturer
11.3.2 Employees and Revenue Level of Neprilysin Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 NEPRILYSIN MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Bioprojet SCR
12.1.1 Company profile
12.1.2 Representative Neprilysin Product
12.1.3 Neprilysin Sales, Revenue, Price and Gross Margin of Bioprojet SCR
12.2 Novartis AG
12.2.1 Company profile
12.2.2 Representative Neprilysin Product
12.2.3 Neprilysin Sales, Revenue, Price and Gross Margin of Novartis AG
12.3 Pharmaleads SA
12.3.1 Company profile
12.3.2 Representative Neprilysin Product
12.3.3 Neprilysin Sales, Revenue, Price and Gross Margin of Pharmaleads SA
12.4 Theravance Biopharma Inc
12.4.1 Company profile
12.4.2 Representative Neprilysin Product
12.4.3 Neprilysin Sales, Revenue, Price and Gross Margin of Theravance Biopharma Inc
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NEPRILYSIN
13.1 Industry Chain of Neprilysin
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF NEPRILYSIN
14.1 Cost Structure Analysis of Neprilysin
14.2 Raw Materials Cost Analysis of Neprilysin
14.3 Labor Cost Analysis of Neprilysin
14.4 Manufacturing Expenses Analysis of Neprilysin
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Neprilysin in This Report
1.2 Commercial Types of Neprilysin
1.2.1 TD-0714
1.2.2 STR-324
1.2.3 PL-265
1.2.4 LHW-090
1.2.5 Others
1.3 Downstream Application of Neprilysin
1.3.1 Acute Heart Failure
1.3.2 Cancer Pain
1.3.3 Hypertension
1.3.4 Alzheimer's Disease
1.3.5 Others
1.4 Development History of Neprilysin
1.5 Market Status and Trend of Neprilysin 2013-2023
1.5.1 Global Neprilysin Market Status and Trend 2013-2023
1.5.2 Regional Neprilysin Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Neprilysin 2013-2017
2.2 Sales Market of Neprilysin by Regions
2.2.1 Sales Volume of Neprilysin by Regions
2.2.2 Sales Value of Neprilysin by Regions
2.3 Production Market of Neprilysin by Regions
2.4 Global Market Forecast of Neprilysin 2018-2023
2.4.1 Global Market Forecast of Neprilysin 2018-2023
2.4.2 Market Forecast of Neprilysin by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Neprilysin by Types
3.2 Sales Value of Neprilysin by Types
3.3 Market Forecast of Neprilysin by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Neprilysin by Downstream Industry
4.2 Global Market Forecast of Neprilysin by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Neprilysin Market Status by Countries
5.1.1 North America Neprilysin Sales by Countries (2013-2017)
5.1.2 North America Neprilysin Revenue by Countries (2013-2017)
5.1.3 United States Neprilysin Market Status (2013-2017)
5.1.4 Canada Neprilysin Market Status (2013-2017)
5.1.5 Mexico Neprilysin Market Status (2013-2017)
5.2 North America Neprilysin Market Status by Manufacturers
5.3 North America Neprilysin Market Status by Type (2013-2017)
5.3.1 North America Neprilysin Sales by Type (2013-2017)
5.3.2 North America Neprilysin Revenue by Type (2013-2017)
5.4 North America Neprilysin Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Neprilysin Market Status by Countries
6.1.1 Europe Neprilysin Sales by Countries (2013-2017)
6.1.2 Europe Neprilysin Revenue by Countries (2013-2017)
6.1.3 Germany Neprilysin Market Status (2013-2017)
6.1.4 UK Neprilysin Market Status (2013-2017)
6.1.5 France Neprilysin Market Status (2013-2017)
6.1.6 Italy Neprilysin Market Status (2013-2017)
6.1.7 Russia Neprilysin Market Status (2013-2017)
6.1.8 Spain Neprilysin Market Status (2013-2017)
6.1.9 Benelux Neprilysin Market Status (2013-2017)
6.2 Europe Neprilysin Market Status by Manufacturers
6.3 Europe Neprilysin Market Status by Type (2013-2017)
6.3.1 Europe Neprilysin Sales by Type (2013-2017)
6.3.2 Europe Neprilysin Revenue by Type (2013-2017)
6.4 Europe Neprilysin Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Neprilysin Market Status by Countries
7.1.1 Asia Pacific Neprilysin Sales by Countries (2013-2017)
7.1.2 Asia Pacific Neprilysin Revenue by Countries (2013-2017)
7.1.3 China Neprilysin Market Status (2013-2017)
7.1.4 Japan Neprilysin Market Status (2013-2017)
7.1.5 India Neprilysin Market Status (2013-2017)
7.1.6 Southeast Asia Neprilysin Market Status (2013-2017)
7.1.7 Australia Neprilysin Market Status (2013-2017)
7.2 Asia Pacific Neprilysin Market Status by Manufacturers
7.3 Asia Pacific Neprilysin Market Status by Type (2013-2017)
7.3.1 Asia Pacific Neprilysin Sales by Type (2013-2017)
7.3.2 Asia Pacific Neprilysin Revenue by Type (2013-2017)
7.4 Asia Pacific Neprilysin Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Neprilysin Market Status by Countries
8.1.1 Latin America Neprilysin Sales by Countries (2013-2017)
8.1.2 Latin America Neprilysin Revenue by Countries (2013-2017)
8.1.3 Brazil Neprilysin Market Status (2013-2017)
8.1.4 Argentina Neprilysin Market Status (2013-2017)
8.1.5 Colombia Neprilysin Market Status (2013-2017)
8.2 Latin America Neprilysin Market Status by Manufacturers
8.3 Latin America Neprilysin Market Status by Type (2013-2017)
8.3.1 Latin America Neprilysin Sales by Type (2013-2017)
8.3.2 Latin America Neprilysin Revenue by Type (2013-2017)
8.4 Latin America Neprilysin Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Neprilysin Market Status by Countries
9.1.1 Middle East and Africa Neprilysin Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Neprilysin Revenue by Countries (2013-2017)
9.1.3 Middle East Neprilysin Market Status (2013-2017)
9.1.4 Africa Neprilysin Market Status (2013-2017)
9.2 Middle East and Africa Neprilysin Market Status by Manufacturers
9.3 Middle East and Africa Neprilysin Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Neprilysin Sales by Type (2013-2017)
9.3.2 Middle East and Africa Neprilysin Revenue by Type (2013-2017)
9.4 Middle East and Africa Neprilysin Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF NEPRILYSIN
10.1 Global Economy Situation and Trend Overview
10.2 Neprilysin Downstream Industry Situation and Trend Overview
CHAPTER 11 NEPRILYSIN MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Neprilysin by Major Manufacturers
11.2 Production Value of Neprilysin by Major Manufacturers
11.3 Basic Information of Neprilysin by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Neprilysin Major Manufacturer
11.3.2 Employees and Revenue Level of Neprilysin Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 NEPRILYSIN MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Bioprojet SCR
12.1.1 Company profile
12.1.2 Representative Neprilysin Product
12.1.3 Neprilysin Sales, Revenue, Price and Gross Margin of Bioprojet SCR
12.2 Novartis AG
12.2.1 Company profile
12.2.2 Representative Neprilysin Product
12.2.3 Neprilysin Sales, Revenue, Price and Gross Margin of Novartis AG
12.3 Pharmaleads SA
12.3.1 Company profile
12.3.2 Representative Neprilysin Product
12.3.3 Neprilysin Sales, Revenue, Price and Gross Margin of Pharmaleads SA
12.4 Theravance Biopharma Inc
12.4.1 Company profile
12.4.2 Representative Neprilysin Product
12.4.3 Neprilysin Sales, Revenue, Price and Gross Margin of Theravance Biopharma Inc
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NEPRILYSIN
13.1 Industry Chain of Neprilysin
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF NEPRILYSIN
14.1 Cost Structure Analysis of Neprilysin
14.2 Raw Materials Cost Analysis of Neprilysin
14.3 Labor Cost Analysis of Neprilysin
14.4 Manufacturing Expenses Analysis of Neprilysin
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
